Affiliation: | 1. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan Contribution: Data curation (equal), Formal analysis (equal), Validation (equal), Writing - original draft (equal);2. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan;3. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan Contribution: Supervision (supporting);4. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan Contribution: Supervision (supporting), Writing - original draft (supporting);5. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan Contribution: Resources (supporting);6. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan Contribution: Visualization (supporting);7. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan Contribution: Validation (supporting);8. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan Contribution: Validation (supporting);9. R&D Center, ID Pharma Co., Ltd, Tsukuba, Japan Contribution: Resources (equal) |